J. Bariola

发表

Launching a comparative effectiveness adaptive platform trial of monoclonal antibodies for COVID-19 in 21 days

David T. Huang, C. Seymour, D. Angus, 2021, Contemporary Clinical Trials.

A Learning Health System Randomized Trial of Monoclonal Antibodies for Covid-19

C. Seymour, G. Snyder, D. Angus, 2021, medRxiv.

Effectiveness of casirivimab and imdevimab, and sotrovimab during Delta variant surge: a prospective cohort study and comparative effectiveness randomized trial

C. Seymour, G. Snyder, D. Angus, 2021, medRxiv.

Progressive Resistance Muscle Strength Training of Hospitalized Frail Elderly

M. Bopp, D. Sullivan, P. Wall, 2001, American journal of physical medicine & rehabilitation.

The comparative effectiveness of COVID-19 monoclonal antibodies: A learning health system randomized clinical trial

David T. Huang, C. Seymour, D. Yealy, 2022, Contemporary Clinical Trials.

Tele‐antimicrobial stewardship programs: A review of the literature and the role of the pharmacist

T. Khadem, E. McCreary, J. Bariola, 2021, JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY.

Association of Subcutaneous or Intravenous Administration of Casirivimab and Imdevimab Monoclonal Antibodies With Clinical Outcomes in Adults With COVID-19

David T. Huang, C. Seymour, D. Yealy, 2022, JAMA network open.

A learning health system approach to the COVID‐19 pandemic: System‐wide changes in clinical practice and 30‐day mortality among hospitalized patients

David T. Huang, D. Yealy, G. Snyder, 2021, medRxiv.

Impact of Clinical Decision Support System Implementation at a Community Hospital With an Existing Tele-Antimicrobial Stewardship Program

T. Khadem, E. McCreary, J. Bariola, 2022, Open forum infectious diseases.

Establishing a Distribution Network for COVID-19 Monoclonal Antibody Therapy Across a Large Health System During a Global Pandemic

D. Yealy, G. Snyder, D. White, 2021, Open forum infectious diseases.

Evaluation of Bebtelovimab for Treatment of Covid-19 During the SARS-CoV-2 Omicron Variant Era

David T. Huang, D. Yealy, G. Snyder, 2022, Open forum infectious diseases.

Current Antifungal Agents for Treatment of Central Nervous System Infections

J. Bariola, Katrina S. Coulter, 2014, Current Fungal Infection Reports.

Blastomyces dermatitidis Antigen Detection by Quantitative Enzyme Immunoassay

L. Wheat, P. Connolly, J. Bariola, 2011, Clinical and Vaccine Immunology.

Blastomycosis of the central nervous system: a multicenter review of diagnosis and treatment in the modern era.

Patty W. Wright, P. Pappas, L. Proia, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Detection of Blastomyces dermatitidis antigen in patients with newly diagnosed blastomycosis.

P. Gubbins, L. Wheat, M. Durkin, 2011, Diagnostic microbiology and infectious disease.

Treatment of endemic mycoses

J. Bariola, Keyur S. Vyas, R. Bradsher, 2010, Expert review of respiratory medicine.

Comparison of Indirect Fungal Diagnostic Tests in Patients With Proven Histoplasmosis

J. Bariola, R. Dare, G. Krishnan, 2022, Open forum infectious diseases.

Pulmonary blastomycosis.

J. Bariola, Keyur S. Vyas, 2011, Seminars in respiratory and critical care medicine.

Advances in the serodiagnosis of blastomycosis

J. Bariola, Keyur S. Vyas, R. Bradsher, 2008 .

The Role of Second-Generation Antifungal Triazoles for Treatment of the Endemic Mycoses

D. Andes, A. Freifeld, J. Bariola, 2010, Current infectious disease reports.

Candida lusitaniae septic arthritis: case report and review of the literature.

J. Bariola, M. Saccente, 2008, Diagnostic microbiology and infectious disease.

Association of subcutaneous or intravenous route of administration of casirivimab and imdevimab monoclonal antibodies with clinical outcomes in COVID-19.

David T. Huang, C. Seymour, D. Yealy, 2021, medRxiv.

Evolving Real-World Effectiveness of Monoclonal Antibodies for Treatment of COVID-19

David T. Huang, C. Seymour, D. Yealy, 2023, Annals of Internal Medicine.

Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection

David T. Huang, C. Seymour, D. Angus, 2021, Open forum infectious diseases.

Effectiveness of Casirivimab-Imdevimab and Sotrovimab During a SARS-CoV-2 Delta Variant Surge

David T. Huang, C. Seymour, D. Yealy, 2022, JAMA network open.

Impact of monoclonal antibody treatment on hospitalization and mortality among non-hospitalized adults with SARS-CoV-2 infection

C. Seymour, D. Angus, D. Yealy, 2021, medRxiv.

Clinical Impact of Accelerate PhenoTM Rapid Blood Culture Detection System in Bacteremic Patients.

J. Painter, J. Bariola, K. Lusardi, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

In-Person Versus Tele-Infectious Disease (Tele-ID) Care: Is One Better?

J. Mellors, J. Bariola, Nupur Gupta, 2022, Open forum infectious diseases.

The UPMC OPTIMISE-C19 (OPtimizing Treatment and Impact of Monoclonal antIbodieS through Evaluation for COVID-19) trial: a structured summary of a study protocol for an open-label, pragmatic, comparative effectiveness platform trial with response-adaptive randomization

David T. Huang, C. Seymour, D. Angus, 2021, Trials.

Evolving Real-World Effectiveness of Monoclonal Antibodies for Treatment of COVID-19

David T. Huang, C. Seymour, D. Yealy, 2023, Annals of Internal Medicine.

Bilateral Open Femoral Fracture Complicated by Wound Botulism: A Case Report.

J. Gruenwald, S. Rudnicki, J. Bariola, 2011, JBJS case connector.

2083. A Targeted Remote Audit and Feedback Intervention Utilizing a Local Non-ID Trained Pharmacist

T. Khadem, J. Bariola, J. Kraft, 2019, Open Forum Infectious Diseases.

Evaluation of fidaxomicin use in community hospitals after a clinical guideline change at a large health system and opportunities for stewardship

T. Khadem, J. Bariola, M. Nguyen, 2022, Infection Control & Hospital Epidemiology.